Literature DB >> 35379909

Disrupted long-range gene regulations elucidate shared tissue-specific mechanisms of neuropsychiatric disorders.

Jingqi Chen1,2,3, Liting Song4,5, Anyi Yang4,5, Guiying Dong4,5, Xing-Ming Zhao6,7,8.   

Abstract

Neurological and psychiatric disorders have overlapped phenotypic profiles, but the underlying tissue-specific functional processes remain largely unknown. In this study, we explore the shared tissue-specificity among 14 neuropsychiatric disorders through the disrupted long-range gene regulations by GWAS-identified regulatory SNPs. Through Hi-C interactions, averagely 38.0% and 17.2% of the intergenic regulatory SNPs can be linked to target protein-coding genes in brain and non-brain tissues, respectively. Interestingly, while the regulatory target genes in the brain tend to enrich in nervous system development related processes, those in the non-brain tissues are inclined to interfere with synapse and neuroinflammation related processes. Compared to psychiatric disorders, neurological disorders present more prominently the neuroinflammatory processes in both brain and non-brain tissues, indicating an intrinsic difference in mechanisms. Through tissue-specific gene regulatory networks, we then constructed disorder similarity networks in two brain and three non-brain tissues, highlighting both known disorder clusters (e.g. the neurodevelopmental disorders) and unexpected disorder clusters (e.g. Parkinson's disease is consistently grouped with psychiatric disorders). We showcase the potential pharmaceutical applications of the small bowel and its disorder clusters, illustrated by the known drug targets NR1I3 and NFACT1, and their small bowel-specific regulatory modules. In conclusion, disrupted long-range gene regulations in both brain and non-brain tissues contribute to the similarity among distinct clusters of neuropsychiatric disorders, and the tissue-specifically shared functions and regulators for disease clusters may provide insights for future therapeutic investigations.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35379909     DOI: 10.1038/s41380-022-01529-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  43 in total

1.  Systematic localization of common disease-associated variation in regulatory DNA.

Authors:  Matthew T Maurano; Richard Humbert; Eric Rynes; Robert E Thurman; Eric Haugen; Hao Wang; Alex P Reynolds; Richard Sandstrom; Hongzhu Qu; Jennifer Brody; Anthony Shafer; Fidencio Neri; Kristen Lee; Tanya Kutyavin; Sandra Stehling-Sun; Audra K Johnson; Theresa K Canfield; Erika Giste; Morgan Diegel; Daniel Bates; R Scott Hansen; Shane Neph; Peter J Sabo; Shelly Heimfeld; Antony Raubitschek; Steven Ziegler; Chris Cotsapas; Nona Sotoodehnia; Ian Glass; Shamil R Sunyaev; Rajinder Kaul; John A Stamatoyannopoulos
Journal:  Science       Date:  2012-09-05       Impact factor: 47.728

2.  Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study.

Authors:  Yang Shen; Jintian Xu; Zhiyong Li; Yichen Huang; Ye Yuan; Jixiang Wang; Meng Zhang; Songnian Hu; Ying Liang
Journal:  Schizophr Res       Date:  2018-01-17       Impact factor: 4.939

3.  Multi-tissue transcriptome analyses identify genetic mechanisms underlying neuropsychiatric traits.

Authors:  Eric R Gamazon; Aeilko H Zwinderman; Nancy J Cox; Damiaan Denys; Eske M Derks
Journal:  Nat Genet       Date:  2019-05-13       Impact factor: 38.330

Review 4.  Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders.

Authors:  Patrick F Sullivan; Daniel H Geschwind
Journal:  Cell       Date:  2019-03-21       Impact factor: 41.582

5.  The psychiatric GWAS consortium: big science comes to psychiatry.

Authors:  Patrick F Sullivan
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

6.  Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.

Authors:  Ping Liu; Li Wu; Guoping Peng; Yuqiu Han; Ruiqi Tang; Jianping Ge; Lijiang Zhang; Longfei Jia; Siqing Yue; Kai Zhou; Lanjuan Li; Benyan Luo; Baohong Wang
Journal:  Brain Behav Immun       Date:  2019-05-04       Impact factor: 7.217

Review 7.  Molecular mechanisms underlying noncoding risk variations in psychiatric genetic studies.

Authors:  X Xiao; H Chang; M Li
Journal:  Mol Psychiatry       Date:  2017-01-03       Impact factor: 15.992

8.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019.

Authors:  Annalisa Buniello; Jacqueline A L MacArthur; Maria Cerezo; Laura W Harris; James Hayhurst; Cinzia Malangone; Aoife McMahon; Joannella Morales; Edward Mountjoy; Elliot Sollis; Daniel Suveges; Olga Vrousgou; Patricia L Whetzel; Ridwan Amode; Jose A Guillen; Harpreet S Riat; Stephen J Trevanion; Peggy Hall; Heather Junkins; Paul Flicek; Tony Burdett; Lucia A Hindorff; Fiona Cunningham; Helen Parkinson
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

9.  Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes.

Authors:  Michael Song; Xiaoyu Yang; Xingjie Ren; Lenka Maliskova; Bingkun Li; Ian R Jones; Chao Wang; Fadi Jacob; Kenneth Wu; Michela Traglia; Tsz Wai Tam; Kirsty Jamieson; Si-Yao Lu; Guo-Li Ming; Yun Li; Jun Yao; Lauren A Weiss; Jesse R Dixon; Luke M Judge; Bruce R Conklin; Hongjun Song; Li Gan; Yin Shen
Journal:  Nat Genet       Date:  2019-07-31       Impact factor: 38.330

10.  Explaining the disease phenotype of intergenic SNP through predicted long range regulation.

Authors:  Jingqi Chen; Weidong Tian
Journal:  Nucleic Acids Res       Date:  2016-06-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.